Advisor Shares Investments LLC Zynerba Pharmaceuticals, Inc. Transaction History

Advisor Shares Investments LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$3.72 - $5.35 $1.02 Million - $1.46 Million	-273,401 Closed	0 $0
Q2 2021 Jul 27, 2021	SELL	$3.83 - $5.98 $4.84 Million - $7.56 Million	-1,264,138 Reduced 82.22%	273,401 $1.45 Million
Q1 2021 May 11, 2021	BUY	$3.33 - $8.76 $3.09 Million - $8.12 Million	927,494 Added 152.04%	1,537,539 $7.15 Million
Q4 2020 Jan 25, 2021	BUY	$3.27 - $4.64 $840,507 - $1.19 Million	257,036 Added 72.81%	610,045 $2.01 Million
Q3 2020 Nov 12, 2020	SELL	$3.23 - $4.3 $89,393 - $119,006	-27,676 Reduced 7.27%	353,009 $1.17 Million
Q2 2020 Jul 14, 2020	BUY	$3.31 - $6.54 $91,743 - $181,269	27,717 Added 7.85%	380,685 $1.28 Million
Q1 2020 May 13, 2020	BUY	$2.9 - $6.16 $241,433 - $512,838	83,253 Added 30.87%	352,968 $1.35 Million
Q4 2019 Jan 22, 2020	BUY	$5.61 - $8.57 $1.51 Million - $2.31 Million	269,715 New	269,715 $1.63 Million

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Advisor Shares Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Advisor Shares Investments LLC with notifications on news.